<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p135" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_135{left:42px;bottom:624px;letter-spacing:-0.13px;word-spacing:0.03px;}
#t2_135{left:42px;bottom:600px;letter-spacing:-0.08px;}
#t3_135{left:166px;bottom:600px;letter-spacing:-0.09px;}
#t4_135{left:42px;bottom:575px;letter-spacing:-0.14px;}
#t5_135{left:124px;bottom:575px;letter-spacing:-0.1px;}
#t6_135{left:42px;bottom:551px;letter-spacing:-0.12px;}
#t7_135{left:124px;bottom:551px;letter-spacing:-0.09px;}
#t8_135{left:42px;bottom:526px;letter-spacing:-0.12px;}
#t9_135{left:124px;bottom:526px;letter-spacing:-0.09px;}
#ta_135{left:42px;bottom:502px;letter-spacing:-0.12px;}
#tb_135{left:124px;bottom:502px;letter-spacing:-0.08px;}
#tc_135{left:124px;bottom:484px;letter-spacing:-0.09px;}
#td_135{left:143px;bottom:484px;letter-spacing:-0.09px;}
#te_135{left:921px;bottom:484px;letter-spacing:-0.09px;}
#tf_135{left:940px;bottom:484px;letter-spacing:-0.07px;}
#tg_135{left:124px;bottom:465px;letter-spacing:-0.09px;}
#th_135{left:80px;bottom:441px;letter-spacing:-0.12px;}
#ti_135{left:124px;bottom:441px;letter-spacing:-0.09px;}
#tj_135{left:80px;bottom:416px;letter-spacing:-0.12px;}
#tk_135{left:124px;bottom:416px;letter-spacing:-0.09px;}
#tl_135{left:80px;bottom:392px;letter-spacing:-0.12px;}
#tm_135{left:124px;bottom:392px;letter-spacing:-0.09px;}
#tn_135{left:42px;bottom:367px;letter-spacing:-0.12px;}
#to_135{left:124px;bottom:367px;letter-spacing:-0.09px;}
#tp_135{left:716px;bottom:367px;letter-spacing:-0.09px;}
#tq_135{left:736px;bottom:367px;letter-spacing:-0.08px;}
#tr_135{left:124px;bottom:347px;letter-spacing:-0.1px;}
#ts_135{left:266px;bottom:342px;}
#tt_135{left:272px;bottom:347px;}
#tu_135{left:278px;bottom:355px;}
#tv_135{left:80px;bottom:323px;letter-spacing:-0.12px;}
#tw_135{left:124px;bottom:323px;letter-spacing:-0.09px;}
#tx_135{left:80px;bottom:298px;letter-spacing:-0.12px;}
#ty_135{left:124px;bottom:295px;letter-spacing:-0.09px;}
#tz_135{left:564px;bottom:290px;}
#t10_135{left:570px;bottom:295px;}
#t11_135{left:576px;bottom:302px;}
#t12_135{left:36px;bottom:271px;}
#t13_135{left:43px;bottom:264px;letter-spacing:0.12px;}
#t14_135{left:36px;bottom:253px;}
#t15_135{left:43px;bottom:245px;letter-spacing:0.19px;}
#t16_135{left:74px;bottom:243px;}
#t17_135{left:83px;bottom:245px;letter-spacing:0.12px;}
#t18_135{left:36px;bottom:227px;letter-spacing:0.12px;}
#t19_135{left:36px;bottom:202px;letter-spacing:0.11px;}
#t1a_135{left:77px;bottom:202px;letter-spacing:0.11px;word-spacing:0.01px;}
#t1b_135{left:36px;bottom:183px;letter-spacing:0.11px;word-spacing:0.01px;}
#t1c_135{left:36px;bottom:778px;letter-spacing:-0.22px;word-spacing:0.13px;}
#t1d_135{left:36px;bottom:760px;letter-spacing:-0.1px;}
#t1e_135{left:36px;bottom:742px;letter-spacing:-0.12px;word-spacing:0.02px;}
#t1f_135{left:36px;bottom:723px;letter-spacing:-0.09px;}
#t1g_135{left:655px;bottom:723px;letter-spacing:-0.1px;}
#t1h_135{left:709px;bottom:723px;letter-spacing:-0.15px;word-spacing:0.06px;}
#t1i_135{left:36px;bottom:705px;letter-spacing:-0.1px;word-spacing:0.01px;}
#t1j_135{left:36px;bottom:687px;letter-spacing:-0.09px;}
#t1k_135{left:1090px;bottom:108px;letter-spacing:-0.11px;}
#t1l_135{left:36px;bottom:73px;letter-spacing:0.12px;word-spacing:-0.08px;}
#t1m_135{left:36px;bottom:56px;letter-spacing:0.12px;}
#t1n_135{left:880px;bottom:56px;letter-spacing:0.03px;}
#t1o_135{left:1004px;bottom:56px;letter-spacing:0.08px;}
#t1p_135{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#t1q_135{left:285px;bottom:827px;letter-spacing:-0.27px;}
#t1r_135{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t1s_135{left:341px;bottom:30px;}
#t1t_135{left:348px;bottom:25px;letter-spacing:0.11px;}
#t1u_135{left:377px;bottom:30px;}
#t1v_135{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t1w_135{left:540px;bottom:30px;}
#t1x_135{left:546px;bottom:25px;letter-spacing:0.07px;}
#t1y_135{left:996px;bottom:873px;letter-spacing:-0.1px;}
#t1z_135{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#t20_135{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#t21_135{left:1128px;bottom:28px;letter-spacing:-0.12px;}
#t22_135{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_135{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s1_135{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s2_135{font-size:17px;font-family:Arial-ItalicMT_kb;color:#000;}
.s3_135{font-size:17px;font-family:ArialMT_k0;color:#000;}
.s4_135{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s5_135{font-size:14px;font-family:ArialMT_5tg;color:#000;}
.s6_135{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s7_135{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s8_135{font-size:15px;font-family:ArialMT_k0;color:#000;}
.s9_135{font-size:15px;font-family:Arial-ItalicMT_kb;color:#000;}
.sa_135{font-size:17px;font-family:Arial-BoldItalicMT_kg;color:#000;}
.sb_135{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sc_135{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.sd_135{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.se_135{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.sf_135{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.sg_135{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts135" type="text/css" >

@font-face {
	font-family: Arial-BoldItalicMT_kg;
	src: url("fonts/Arial-BoldItalicMT_kg.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-ItalicMT_kb;
	src: url("fonts/Arial-ItalicMT_kb.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

</style>
<div id="pg135Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg135" style="-webkit-user-select: none;"><object width="1210" height="935" data="135/135.svg" type="image/svg+xml" id="pdf135" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_135" class="t s0_135">Regional Lymph Nodes (N) </span>
<span id="t2_135" class="t s0_135">Clinical N (cN): </span><span id="t3_135" class="t s1_135">For patients who are treated with primary nonsurgical treatment without a cervical lymph node dissection. </span>
<span id="t4_135" class="t s0_135">NX </span><span id="t5_135" class="t s1_135">Regional lymph nodes cannot be assessed </span>
<span id="t6_135" class="t s0_135">N0 </span><span id="t7_135" class="t s1_135">No regional lymph node metastasis </span>
<span id="t8_135" class="t s0_135">N1 </span><span id="t9_135" class="t s1_135">Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(-) </span>
<span id="ta_135" class="t s0_135">N2 </span><span id="tb_135" class="t s1_135">Metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); </span>
<span id="tc_135" class="t s2_135">or </span><span id="td_135" class="t s1_135">metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); </span><span id="te_135" class="t s2_135">or </span><span id="tf_135" class="t s1_135">in bilateral or </span>
<span id="tg_135" class="t s1_135">contralateral lymph nodes, none larger than 6 cm in greatest dimension, ENE(-) </span>
<span id="th_135" class="t s1_135">N2a </span><span id="ti_135" class="t s1_135">Metastasis in a single ipsilateral node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-) </span>
<span id="tj_135" class="t s1_135">N2b </span><span id="tk_135" class="t s1_135">Metastases in multiple ipsilateral nodes, none larger than 6 cm in greatest dimension and ENE(-) </span>
<span id="tl_135" class="t s1_135">N2c </span><span id="tm_135" class="t s1_135">Metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-) </span>
<span id="tn_135" class="t s0_135">N3 </span><span id="to_135" class="t s1_135">Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); </span><span id="tp_135" class="t s2_135">or </span><span id="tq_135" class="t s1_135">metastasis in any node(s) with clinically </span>
<span id="tr_135" class="t s3_135">overt ENE(+) (ENE </span>
<span id="ts_135" class="t s4_135">c </span>
<span id="tt_135" class="t s1_135">) </span>
<span id="tu_135" class="t s5_135">2 </span>
<span id="tv_135" class="t s1_135">N3a </span><span id="tw_135" class="t s3_135">Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(−) </span>
<span id="tx_135" class="t s1_135">N3b </span>
<span id="ty_135" class="t s3_135">Metastasis in any node(s) with clinically overt ENE(+) (ENE </span>
<span id="tz_135" class="t s4_135">c </span>
<span id="t10_135" class="t s1_135">) </span>
<span id="t11_135" class="t s5_135">2 </span>
<span id="t12_135" class="t s4_135">1 </span>
<span id="t13_135" class="t s6_135">Midline nodes are considered ipsilateral nodes. </span>
<span id="t14_135" class="t s4_135">2 </span>
<span id="t15_135" class="t s6_135">ENE </span>
<span id="t16_135" class="t s7_135">c </span>
<span id="t17_135" class="t s8_135" data-mappings='[[5,"fi"],[33,"fi"],[78,"fi"]]'>is deﬁned as invasion of skin, inﬁltration of musculature, dense tethering or ﬁxation to adjacent structures, or cranial nerve, brachial plexus, </span>
<span id="t18_135" class="t s6_135">sympathetic trunk, or phrenic nerve invasion with dysfunction. </span>
<span id="t19_135" class="t s9_135">Note: </span><span id="t1a_135" class="t s6_135">A designation of “U” or “L” may be used for any N category to indicate metastasis above the lower border of the cricoid (U) or below the lower </span>
<span id="t1b_135" class="t s8_135">border of the cricoid (L). Similarly, clinical and pathological ENE should be recorded as ENE(−) or ENE(+). </span>
<span id="t1c_135" class="t sa_135">Table 7 </span>
<span id="t1d_135" class="t s0_135">American Joint Committee on Cancer (AJCC) </span>
<span id="t1e_135" class="t s0_135">TNM Staging System for Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck (8th ed., 2017) </span>
<span id="t1f_135" class="t s1_135">(Squamous cell carcinoma and salivary gland carcinoma of all head and neck sites </span><span id="t1g_135" class="t s2_135">except </span><span id="t1h_135" class="t s1_135">HPV-related oropharynx cancer, nasopharynx cancer, </span>
<span id="t1i_135" class="t s1_135">melanoma, thyroid carcinoma, and sarcoma. Staging of the patient who presents with an occult primary tumor and EBV-unrelated and HPV-unrelated </span>
<span id="t1j_135" class="t s1_135">metastatic cervical lymphadenopathy is also included.) </span>
<span id="t1k_135" class="t sb_135">Continued </span>
<span id="t1l_135" class="t s6_135">Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging Manual, Eighth Edition </span>
<span id="t1m_135" class="t s6_135">(2017) published by Springer International Publishing. (For complete information and data supporting the staging tables, visit </span><span id="t1n_135" class="t sc_135">www.springer.com</span><span id="t1o_135" class="t s6_135">.) </span>
<span id="t1p_135" class="t sd_135">NCCN Guidelines Version 4.2024 </span>
<span id="t1q_135" class="t sd_135">Head and Neck Cancers </span>
<span id="t1r_135" class="t s7_135">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t1s_135" class="t se_135">® </span>
<span id="t1t_135" class="t s7_135">(NCCN </span>
<span id="t1u_135" class="t se_135">® </span>
<span id="t1v_135" class="t s7_135">), All rights reserved. NCCN Guidelines </span>
<span id="t1w_135" class="t se_135">® </span>
<span id="t1x_135" class="t s7_135">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t1y_135" class="t sf_135">NCCN Guidelines Index </span>
<span id="t1z_135" class="t sf_135">Table of Contents </span>
<span id="t20_135" class="t sf_135">Discussion </span>
<span id="t21_135" class="t s0_135">ST-15 </span>
<span id="t22_135" class="t sg_135">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
